Vice President Operations
Patrick Stragier joined Promethera Biosciences in September 2015. Patrick Stragier is responsible for developing the Promethera production and operations strategy. He oversees the production of HepaStem for ongoing clinical trials. In addition, he is responsible for the strategy for scaling up production for later stage clinical trials, market needs and commercialisation. Patrick contributes to the optimization of Promethera’s production processes, meeting Promethera’s high industrial standards whilst maintaining affordable costs both for the patient and the community. Patrick Stragier is the Vice President of Operations, in charge of Manufacturing and Quality Control at Promethera Biosciences. Patrick is a biochemist with more than 25 years of international operational and managerial experience. He has worked for biopharmaceutical companies such as Solvay, DSM-Biologics, Genzyme and Lonza. From 2009, he has been working as a consultant specialized in cell therapy. He is co-founder of MaSTherCell.